David Hung

Insider Reports History

Entity
Individual
Location
C/O Axovant Sciences, Inc., 320 West 37 Th Street, 5 Th Floor, New York, NY
Signature
/s/ Stephen Dang, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Hung:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Nuvation Bio Inc. PRESIDENT AND CEO, Director, 10%+ Owner Class A Common Stock 58.8M $95.5M $1.63 Apr 7, 2025 Direct
NovoCure Ltd Director Stock Option (Right to Buy) 6.23K $102K $16.30 Jun 5, 2024 Direct
Nuvation Bio Inc. PRESIDENT AND CEO, Director, 10%+ Owner Stock Option (Right to Buy) 2M Feb 28, 2025 Direct
NovoCure Ltd Director Restricted Stock Units 13.2K Jun 5, 2024 Direct

Insider Reports Filed by David Hung

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NUVB Nuvation Bio Inc. Apr 4, 2025 2 $820K 4 Apr 8, 2025 PRESIDENT AND CEO, Director, 10%+ Owner
NUVB Nuvation Bio Inc. Feb 28, 2025 1 $0 4 Mar 4, 2025 PRESIDENT AND CEO, Director, 10%+ Owner
NVCR NovoCure Ltd Jun 5, 2024 2 $0 4 Jun 6, 2024 Director
NUVB Nuvation Bio Inc. Feb 29, 2024 1 $0 4 Mar 4, 2024 PRESIDENT AND CEO, Director, 10%+ Owner
NVCR NovoCure Ltd Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
NVCR NovoCure Ltd Jun 8, 2022 2 $0 4 Jun 10, 2022 Director
NUVB Nuvation Bio Inc. Feb 28, 2022 1 $0 4 Mar 2, 2022 President and CEO, Director, 10%+ Owner
NVCR NovoCure Ltd Jun 9, 2021 2 $0 4 Jun 11, 2021 Director
NUVB Nuvation Bio Inc. Mar 2, 2021 2 $0 4 Mar 2, 2023 President and CEO, Director, 10%+ Owner